Skip to search boxSkip to navigationSkip to main content

External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents

  • Eftyhia Vardas(corresponding author)
    ,
  • Anna R. Giuliano
    ,
  • Stephen Goldstone
    ,
  • Joel M. Palefsky
    ,
  • Edson D. Moreira
    ,
  • Mary E. Penny
*Corresponding author for this work
  • Lancet Laboratories
    ,
  • Stellenbosch University
    ,
  • University of South Florida
    ,
  • Icahn School of Medicine at Mount Sinai
    ,
  • University of California at San Francisco
    ,
  • Fundação Oswaldo Cruz
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background. We examined the baseline prevalence of penile, scrotal, and perineal/perianal human papillomavirus (HPV) in heterosexual men (HM). We also evaluated baseline characteristics of HM to assess factors associated with prevalent HPV detection. Methods. We tested serum samples from 3463 HM aged 16-24 years with 1-5 lifetime female sexual partners for antibodies to HPV 6, 11, 16, and 18. We collected baseline swab specimens for the detection of DNA of HPV 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 from 3 areas: penile, scrotal, and perineal/perianal. Risk factors for prevalent HPV DNA detection were evaluated. Results. The prevalence of any tested HPV type was 18.7% at the penis, 13.1% at the scrotum, 7.9% at the perineal/perianal region, and 21.0% at any site. Having >3 lifetime female sexual partners had the greatest impact on HPV prevalence: odds ratio (OR) 3.2 (95% confidence interval (CI) 2.1-4.9) for HPV 6, 11, 16, and 18; and OR 4.5 (95% CI 3.3-6.1) for all HPV types tested. HPV DNA detection was highest in Africa. Neither condom usage nor circumcision was associated with HPV DNA prevalence. Conclusion. Genital-HPV DNA detection is common in young, sexually active HM. We found HPV to be most prevalent in African men and least prevalent in men from the Asia-Pacific region. Increased numbers of sexual partners was an important risk factor for HPV DNA prevalence.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 58-65 (8 pages)

Journal (Volume, Issue Number)

Journal of Infectious Diseases (Volume 203, Issue 1)

Publication milestones

  • Published - 01/01/2011

Publication status

Published - 01/01/2011

ISSN

0022-1899

Publication IDs

  • Scopus: 79851472653
  • PubMed: 21148497

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.06
Fractional count
16
Fractional count
0.94
Fractional count
1
Fractional count
1
SciVal
FWCI
2.81
SciVal
Author count
17
SciVal
citations
70
SciVal
Paper percentile
94
SciVal
Top percentile
10

PlumX, opens in new tab

Citation count
106
Captures
125
Mentions
2

Funding Details

Potential conflicts of interest: DGF, EM, MP, AG, and JP have received research grants from Merck, either personally or through their institutions. MP and DGF have received research grants from GlaxoSmithKline. AG, SG, DGF, RJH, and EM have received honoraria from Merck for speaking engagements or board membership. SG, AG, DGF, JP and EM have received travel reimbursement from Merck related to scientific meetings. CA has an approved, filed, or pending patent related to subject matter discussed in this manuscript. EG, EB, RMH, DG, JBM, KLL and SV are employees of Merck and may own Merck stock and/or stock options.
FunderFunding numbers
GSK
-